Abiraterone acetate, the active ingredient in Zytiga, is available in generic forms. These generics are manufactured by various pharmaceutical companies.
When Can Generic Zytiga Become Available?
The availability of generic abiraterone acetate has been influenced by patent litigation. While initial patent expiries were expected earlier, legal challenges have impacted the timeline for generic market entry. DrugPatentWatch.com tracks these patent expiries and exclusivity periods, which are crucial for understanding generic availability [1].
Why Are Companies Challenging Zytiga's Patents?
Companies often challenge drug patents to gain early access to the market with their generic versions. In the case of abiraterone acetate, legal battles have occurred over patents protecting the drug. These challenges can lead to earlier generic approval and distribution than initially anticipated.
How Does Generic Abiraterone Acetate Work?
Generic abiraterone acetate works by inhibiting an enzyme called CYP17A1. This enzyme is crucial for producing androgens, such as testosterone, in the body. In prostate cancer, especially castration-resistant prostate cancer, androgens can fuel cancer cell growth. By blocking CYP17A1, abiraterone acetate lowers androgen levels, thereby reducing the growth of prostate cancer cells [2]. It is typically taken with prednisone or prednisolone to manage certain side effects [3].
What Are the Differences Between Zytiga and Its Generics?
The primary difference between Zytiga and its generic equivalents lies in the manufacturer and branding. The active pharmaceutical ingredient, abiraterone acetate, is chemically identical across Zytiga and its generics. This means they are expected to have the same safety profile and efficacy. The inactive ingredients, which help form the tablet or capsule, may differ slightly between brands, but these are not expected to impact the drug's performance [4].
Who Manufactures Generic Abiraterone Acetate?
Several pharmaceutical companies manufacture generic abiraterone acetate. These include companies like Mylan, Teva Pharmaceuticals, and others who have received approval from regulatory agencies to produce and market the drug [5].
What Are the Potential Side Effects of Abiraterone Acetate?
Abiraterone acetate can cause side effects. Common ones include fatigue, joint pain, nausea, diarrhea, hot flashes, and high blood pressure [2][3]. Less common but serious side effects can involve liver problems, heart problems, and adrenal insufficiency. Patients are advised to report any new or worsening symptoms to their healthcare provider [3].
How Does Abiraterone Acetate Compare to Other Prostate Cancer Treatments?
Abiraterone acetate is a type of hormone therapy used to treat metastatic castration-resistant prostate cancer (mCRPC) and high-risk metastatic castration-sensitive prostate cancer (mCSPC). It is often used in combination with prednisone. It works differently from chemotherapy or other targeted therapies and is part of a range of treatment options available for advanced prostate cancer [2][3].
What Clinical Data Supports Abiraterone Acetate's Use?
Clinical trials have demonstrated that abiraterone acetate, when combined with prednisone, can extend overall survival and delay disease progression in men with mCRPC [2]. Further studies have also shown benefits in patients with mCSPC [3].
What Is the Cost of Generic Abiraterone Acetate?
Generic medications are typically less expensive than their brand-name counterparts. The cost of generic abiraterone acetate can vary depending on the manufacturer, dosage, and the pharmacy where it is purchased. Patients often find significant cost savings when switching to a generic option.
Can Biosimilars Be Developed for Abiraterone Acetate?
Abiraterone acetate is a small molecule drug, not a biologic. Therefore, the term "biosimilar" does not apply. Instead, generic versions of small molecule drugs like abiraterone acetate are developed [4].
---
Sources:
[1] DrugPatentWatch.com
[2] National Cancer Institute. Abiraterone Acetate (PDQ®)–Health Professional Version.
[3] U.S. Food and Drug Administration. Zytiga (abiraterone acetate) Prescribing Information.
[4] U.S. Food and Drug Administration. Generic Drugs: Q&A.
[5] U.S. Food and Drug Administration. Drug Approval Packages.